Abstract
The differential diagnosis of mineralocorticoid excess involves primary and secondary aldosteronism, adrenal hydroxylation defects with concurrent overproduction of deoxycorticosterone, administration of substances with mineralocorticoid activity, such as drugs and licorice, and overproduction of glucocorticoids, which have associated mineralocorticoid activity. More uncommon syndromes may include a predominantly deoxycorticosterone-producing adenoma and Liddle’s syndrome, a renal tubular disease that mimics mineralocorticoid excess. A postulated mechanism also includes conditions that increase the sensitivity of the tissue to otherwise normal levels of the steroids. These syndromes are generally characterized by the concurrence of hypokalemia and hypertension with or without associated clinical signs of glucocorticoid and androgen excess or deficiency. The differential diagnosis of mineralocorticoid excess can thus be summarized as follows:
-
Primary and secondary aldosteronism
-
11β and 17α defects with deoxycorticosterone overproduction
-
Mineralocorticoid administration (drugs and licorice)
-
Cushing’s syndrome with marked Cortisol overproduction
-
Predominantly deoxycorticosterone-producing adenoma
-
Liddle’s syndrome
-
Increased sensitivity to mineralocorticoids.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC (1977) Renin-aldosterone profiling in hypertension. Ann Intern Med 87: 596–612
Conn JW, Cohen EL, Rovner DR (1964) Suppression of plasma renin activity in primary aldosteronism. JAMA 190: 213–221
Helber A, Wambach G, Hummerich W, Bonner G, Meurer KA, Kaufmann W (1980) Evidence for a subgroup of essential hypertensive with non-suppres- sible excretion of aldosterone during sodium-loading. Klin Wochenschr 58: 439–447
Laragh JH, Sealey J, Brunner HR (1972) The control of aldosterone secretion in normal and hypertensive man: Abnormal renin-aldosterone patterns in low renin hypertension. Am J Med 53: 649–663
Biglieri EG, Slaton PE, Kronfield SJ, Schambelan M (1967) Diagnosis of an aldosterone-producing adenoma in primary aldosteronism. JAMA 201: 100–104
Horton R (1969) Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism. J Clin Invest 48: 1230–1236
Kem DC, Weinberger MH, Mayes DM, Nugent CA (1971) Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128: 380–386
Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP (1979) The diagnosis, localization, and treatment of primary aldosteronism. Ann Intern Med 90: 386–395
Lyons DF, Kem DC, Brown RD, Carollo ML, Hanson C (1982) The use of converting enzyme inhibitor (CEI) as a diagnostic agent for primary aldosteronism. Endocrinology 110 (Suppl): 137
Linde R, Coulam C, Battino R, Rhamy R, Gerlock J, Hollifield J (1979) Localization of aldosterone-producing adenoma by computed tomography. J Clin Endocrinol Metab 49: 642–645
White EA, Schambelan M, Rost CR, Biglieri EG, Moss AA, Korobkin M (1980) Use of computed tomography in diagnosing the cause of primary aldosteronism. N Engl J Med 303: 1503–1507
Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ (1981) The plas-ma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52: 195–198
Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB (1978) Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 46: 552–560
Biglieri EG, Schambelan M, Hirai J, Chang B, Brust N (1979) The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 49: 87–91
Pellnitz W. Schöneshöfer M, Oelkers W (1978) Differentiation between subtypes of primary hyperaldosteronism by multiple steroid measurement after dexamethasone administration. Klin Wochenschr 56: 855–858
Guthrie GP (1981) Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism. J Lab Clin Med 98: 364–373
Gomez-Sanchez C, Kem DC, Kaplan NM (1973) A radioimmunoassay for plasma aldosterone by immunologic purification. J Clin Endocrinol Metab 36: 795–798
Gomez-Sanchez C, Murry BA, Kem DC, Kaplan NM (1975) A direct radioimmunoassay of corticosterone in rat serum. Endocrinology 96: 796–798
Abraham GE, Swerdloff R, Tulchinsky D, Odell WD (1971) Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab 32: 619–624
Ferris JB, Brown J J, Fraser R, Kay AW, Neville AM, O’Muircheartaigh IG, Robertson JIS, Symington T, Lever AF (1970) Hypertension with aldosterone excess and low plasma-renin: Preoperative distinction between patients with and without adrenocortical tumour. Lancet 2: 995–1000
Ulick S (1976) Adrenocortical factors in hypertension 1. Significance of 18-hydroxy-11-deoxyeortieosterone. Am J Cardiol 38: 814–824
Kaplan NM, Cook R, Gulley S (1967) The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism. J Clin Invest 46: 728–734
Biglieri EG, Hane S, Slaton PE, Forsham PH, Herron MA, Horita S (1963) In vivo and in vitro studies of adrenal secretions in Cushing’s syndrome and primary aldosteronism. J Clin Invest 42:516–524
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kem, D.C. et al. (1983). Differentiation of Mineralocorticoid-induced Hypertension. In: Kaufmann, W., Wambach, G., Helber, A., Meurer, KA. (eds) Mineralocorticoids and Hypertension. International Boehringer Mannheim Symposia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69081-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-69081-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-12391-0
Online ISBN: 978-3-642-69081-5
eBook Packages: Springer Book Archive